October 5, 2015
Avita expands Compassionate Use IDE program for ReCell
FDA allows Avita to expand its Compassionate Use Investigational Device Exemption (IDE) program for ReCell.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Adam Kelliher